Early stratification of radiotherapy response by activatable inflammation magnetic resonance imaging.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
15 06 2020
15 06 2020
Historique:
received:
19
09
2019
accepted:
14
05
2020
entrez:
17
6
2020
pubmed:
17
6
2020
medline:
28
8
2020
Statut:
epublish
Résumé
Tumor heterogeneity is one major reason for unpredictable therapeutic outcomes, while stratifying therapeutic responses at an early time may greatly benefit the better control of cancer. Here, we developed a hybrid nanovesicle to stratify radiotherapy response by activatable inflammation magnetic resonance imaging (aiMRI) approach. The high Pearson's correlation coefficient R values are obtained from the correlations between the T
Identifiants
pubmed: 32541769
doi: 10.1038/s41467-020-16771-y
pii: 10.1038/s41467-020-16771-y
pmc: PMC7295999
doi:
Substances chimiques
Reactive Oxygen Species
0
Types de publication
Evaluation Study
Journal Article
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3032Subventions
Organisme : Intramural NIH HHS
ID : ZIA EB000073
Pays : United States
Références
Cuccarese, M. F. et al. Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging. Nat. Commun. 8, 14293 (2017).
pubmed: 28176769
pmcid: 5309815
doi: 10.1038/ncomms14293
Bensch, F. et al. 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer. Nat. Med. 24, 1852–1858 (2018).
pubmed: 30478423
doi: 10.1038/s41591-018-0255-8
Chen, H., Zhang, W., Zhu, G., Xie, J. & Chen, X. Rethinking cancer nanotheranostics. Nat. Rev. Mater. 2, 17024 (2017).
pubmed: 29075517
pmcid: 5654564
doi: 10.1038/natrevmats.2017.24
Hu, C. W. et al. A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia. Nat. Biomed. Eng. 3, 889–891 (2019).
pubmed: 30988472
pmcid: 7051028
doi: 10.1038/s41551-019-0387-2
Dagogo-Jack, I. & Shaw, A. T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 15, 81 (2017).
pubmed: 29115304
doi: 10.1038/nrclinonc.2017.166
Lindsay, K. E. et al. Visualization of early events in mRNA vaccine delivery in non-human primates via PET–CT and near-infrared imaging. Nat. Biomed. Eng. 3, 371–380 (2019).
pubmed: 30936432
doi: 10.1038/s41551-019-0378-3
Rashidian, M. et al. Noninvasive imaging of immune responses. Proc. Natl Acad. Sci. USA 112, 6146–6151 (2015).
pubmed: 25902531
doi: 10.1073/pnas.1502609112
Shuhendler, A. J. et al. Molecular magnetic resonance imaging of tumor response to therapy. Sci. Rep. 5, 14759 (2015).
pubmed: 26440059
pmcid: 4594000
doi: 10.1038/srep14759
Kasoji, S. K., Rivera, J. N., Gessner, R. C., Chang, S. X. & Dayton, P. A. Early assessment of tumor response to radiation therapy using high-resolution quantitative microvascular ultrasound imaging. Theranostics 8, 156–168 (2018).
pubmed: 29290799
pmcid: 5743466
doi: 10.7150/thno.19703
Barker, H. E., Paget, J. T. E., Khan, A. A. & Harrington, K. J. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat. Rev. Cancer 15, 409–425 (2015).
pubmed: 26105538
pmcid: 4896389
doi: 10.1038/nrc3958
Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541–550 (2018).
pubmed: 29686425
pmcid: 29686425
doi: 10.1038/s41591-018-0014-x
Surace, L. et al. Complement Is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response. Immunity 42, 767–777 (2015).
pubmed: 25888260
doi: 10.1016/j.immuni.2015.03.009
Abdelfattah, N. et al. MiR-584-5p potentiates vincristine and radiation response by inducing spindle defects and DNA damage in medulloblastoma. Nat. Commun. 9, 4541 (2018).
pubmed: 30382096
pmcid: 6208371
doi: 10.1038/s41467-018-06808-8
Shin, S. H., Park, S. H., Kim, S. W., Kim, M. & Kim, D. Fluorine MR imaging monitoring of tumor inflammation after high-intensity focused ultrasound ablation. Radiology 287, 476–484 (2018).
pubmed: 29369752
doi: 10.1148/radiol.2017171603
Krause, M., Dubrovska, A., Linge, A. & Baumann, M. Cancer stem cells: radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments. Adv. Drug Deliv. Rev. 109, 63–73 (2017).
pubmed: 26877102
doi: 10.1016/j.addr.2016.02.002
Ellison, D. W. et al. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J. Clin. Oncol. 29, 1400–1407 (2010).
pubmed: 20921458
pmcid: 3525837
doi: 10.1200/JCO.2010.30.2810
Little, R. A. et al. Mapping hypoxia in renal carcinoma with oxygen-enhanced MRI: comparison with intrinsic susceptibility MRI and pathology. Radiology 288, 739–747 (2018).
pubmed: 29869970
pmcid: 6122194
doi: 10.1148/radiol.2018171531
Jeraj, R., Bradshaw, T. & Simončič, U. Molecular imaging to plan radiotherapy and evaluate its efficacy. J. Nucl. Med. 56, 1752–1765 (2015).
pubmed: 26383148
doi: 10.2967/jnumed.114.141424
Zhang, Y. et al. ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages. Cell Res. 23, 898–914 (2013).
pubmed: 23752925
pmcid: 3698641
doi: 10.1038/cr.2013.75
Shi, C. et al. Reprogramming tumor-associated macrophages by nanoparticle-based reactive oxygen species photogeneration. Nano Lett. 18, 7330–7342 (2018).
pubmed: 30339753
doi: 10.1021/acs.nanolett.8b03568
Wang, J., Zhang, Y., Archibong, E., Ligler, F. S. & Gu, Z. Leveraging H
doi: 10.1002/adbi.201700084
Xu, Q., He, C., Xiao, C. & Chen, X. Reactive oxygen species (ROS) responsive polymers for biomedical applications. Macromol. Biosci. 16, 635–646 (2016).
pubmed: 26891447
doi: 10.1002/mabi.201500440
Reth, M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat. Immunol. 3, 1129 (2002).
pubmed: 12447370
doi: 10.1038/ni1202-1129
Takeshima, T. et al. Key role for neutrophils in radiation-induced antitumor immune responses: potentiation with G-CSF. Proc. Natl Acad. Sci. USA 113, 11300–11305 (2016).
pubmed: 27651484
doi: 10.1073/pnas.1613187113
Langford, T. F., Huang, B. K., Lim, J. B., Moon, S. J. & Sikes, H. D. Monitoring the action of redox-directed cancer therapeutics using a human peroxiredoxin-2-based probe. Nat. Commun. 9, 3145 (2018).
pubmed: 30087344
pmcid: 6081480
doi: 10.1038/s41467-018-05557-y
Huang, J., Li, J., Lyu, Y., Miao, Q. & Pu, K. Molecular optical imaging probes for early diagnosis of drug-induced acute kidney injury. Nat. Mater. 18, 1133–1143 (2019).
pubmed: 31133729
doi: 10.1038/s41563-019-0378-4
Ni, D. et al. Molybdenum-based nanoclusters act as antioxidants and ameliorate acute kidney injury in mice. Nat. Commun. 9, 5421 (2018).
pubmed: 30575745
pmcid: 6303396
doi: 10.1038/s41467-018-07890-8
Wang, H. et al. Ultrasensitive magnetic resonance imaging of systemic reactive oxygen species in vivo for early diagnosis of sepsis using activatable nanoprobes. Chem. Sci. 10, 3770–3778 (2019).
pubmed: 30996965
pmcid: 6447818
doi: 10.1039/C8SC04961K
Huang, G. et al. PET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive 64Cu-labelled polymers. Nat. Biomed. Eng. 4, 314–324 (2020).
pubmed: 31235828
doi: 10.1038/s41551-019-0416-1
Zhou, Z. et al. Synchronous chemoradiation nanovesicles by X-Ray triggered cascade of drug release. Angew. Chem. Int. Ed. 57, 8463–8467 (2018).
doi: 10.1002/anie.201802351
Zhou, Z. et al. Artificial local magnetic field inhomogeneity enhances T2 relaxivity. Nat. Commun. 8, 15468 (2017).
pubmed: 28516947
pmcid: 5454366
doi: 10.1038/ncomms15468
Shin, T.-H. et al. A magnetic resonance tuning sensor for the MRI detection of biological targets. Nat. Protoc. 13, 2664–2684 (2018).
pubmed: 30349049
doi: 10.1038/s41596-018-0057-y
Choi, J.-S. et al. Distance-dependent magnetic resonance tuning as a versatile MRI sensing platform for biological targets. Nat. Mater. 16, 537 (2017).
pubmed: 28166216
doi: 10.1038/nmat4846
Grinstead, R. R. The oxidation of ascorbic acid by hydrogen peroxide. Catalysis by ethylenediaminetetraacetato-Iron(III). J. Am. Chem. Soc. 82, 3464–3471 (1960).
doi: 10.1021/ja01498a057
Allen, B. L., Johnson, J. D. & Walker, J. P. Encapsulation and enzyme-mediated release of molecular cargo in polysulfide nanoparticles. ACS Nano 5, 5263–5272 (2011).
pubmed: 21595444
doi: 10.1021/nn201477y
Matsuoka, Y. et al. IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma. Br. J. Cancer 115, 1234 (2016).
pubmed: 27736845
pmcid: 5104896
doi: 10.1038/bjc.2016.327
Formenti, S. C. & Demaria, S. Systemic effects of local radiotherapy. Lancet Oncol. 10, 718–726 (2009).
pubmed: 19573801
pmcid: 2782943
doi: 10.1016/S1470-2045(09)70082-8
Ostrand-Rosenberg, S., Horn, L. A. & Ciavattone, N. G. Radiotherapy both promotes and inhibits myeloid-derived suppressor cell function: novel strategies for preventing the tumor-protective effects of radiotherapy. Front. Oncol. 9, 215–215 (2019).
pubmed: 31001479
pmcid: 6454107
doi: 10.3389/fonc.2019.00215
Ostrand-Rosenberg, S. & Fenselau, C. Myeloid-derived suppressor cells: immune-suppressive cells that impair antitumor immunity and are sculpted by their environment. J. Immunol. 200, 422–431 (2018).
pubmed: 29311384
pmcid: 5765878
doi: 10.4049/jimmunol.1701019
Multhoff, G. & Radons, J. Radiation, inflammation, and immune responses in cancer. Front. Oncol. 2, 1–18 (2012).
Eruslanov, E. B. et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J. Clin. Investig. 124, 5466–5480 (2014).
pubmed: 25384214
doi: 10.1172/JCI77053
Powell, D. R. & Huttenlocher, A. Neutrophils in the tumor microenvironment. Trends Immunol. 37, 41–52 (2016).
pubmed: 26700397
doi: 10.1016/j.it.2015.11.008
Wculek, S. K. & Malanchi, I. Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature 528, 413 (2015).
pubmed: 26649828
pmcid: 4700594
doi: 10.1038/nature16140
Szczerba, B. M. et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature 566, 553–557 (2019).
pubmed: 30728496
doi: 10.1038/s41586-019-0915-y
Kagan, V. E. et al. Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat. Nanotechnol. 5, 354 (2010).
pubmed: 20364135
pmcid: 6714564
doi: 10.1038/nnano.2010.44
Mi, P. et al. A pH-activatable nanoparticle with signal-amplification capabilities for non-invasive imaging of tumour malignancy. Nat. Nanotechnol. 11, 724 (2016).
pubmed: 27183055
doi: 10.1038/nnano.2016.72
Werner, E. J., Datta, A., Jocher, C. J. & Raymond, K. N. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging. Angew. Chem. Int. Ed. 47, 8568–8580 (2008).
doi: 10.1002/anie.200800212
Ananta, J. S. et al. Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast. Nat. Nanotechnol. 5, 815 (2010).
pubmed: 20972435
pmcid: 2974055
doi: 10.1038/nnano.2010.203
Munasinghe, J. P. et al. Arterial spin labeling demonstrates that focal amygdalar glutamatergic agonist infusion leads to rapid diffuse cerebral activation. Acta Neurol. Scand. 121, 209–216 (2010).
pubmed: 19951270
doi: 10.1111/j.1600-0404.2009.01188.x